LMX1B

LIM homeobox transcription factor 1 beta, the group of LIM class homeoboxes

Basic information

Region (hg38): 9:126613928-126701032

Previous symbols: [ "NPS1" ]

Links

ENSG00000136944NCBI:4010OMIM:602575HGNC:6654Uniprot:O60663AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • nail-patella syndrome (Supportive), mode of inheritance: AD
  • nail-patella-like renal disease (Supportive), mode of inheritance: AD
  • nail-patella syndrome (Strong), mode of inheritance: AD
  • nail-patella syndrome (Definitive), mode of inheritance: AD
  • nail-patella syndrome (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Nail-patella syndrome; Focal segmental glomerulosclerosis 10ADOphthalmologic; Pharmacogenomic; RenalIn Nail-patella syndrome, individuals may have open-angle glaucoma, and surveillance and appropriate treatment may be beneficial; Agents that may contribute to glaucoma (as well as NSAIDs as relates to renal function) should be avoided; Medical treatment (eg, ACE inhibitors) may be beneficial in terms of affecting the progression of renal disease; Renal transplantation has been described; In Focal segmental glomerulosclerosis, recognition of disease may allow early management, and renal transplant has been describedDermatologic; Musculoskeletal; Ophthalmologic; Renal9590287; 9618165; 15928687; 17515884; 18414507; 20301311; 21850167; 23687361; 32356190; 32791958
Onset may typically be during adulthood, though surveillance earlier may be warranted given reports of affected individuals in the 3rd decade

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LMX1B gene.

  • not provided (65 variants)
  • Nail-patella syndrome (24 variants)
  • LMX1B-related disorder (5 variants)
  • Nail-patella syndrome;Nail-patella-like renal disease (2 variants)
  • Inherited focal segmental glomerulosclerosis (1 variants)
  • Nephrotic syndrome (1 variants)
  • Nail-patella-like renal disease (1 variants)
  • Nail-patella-like renal disease;Nail-patella syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LMX1B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
75
clinvar
5
clinvar
82
missense
12
clinvar
16
clinvar
109
clinvar
8
clinvar
145
nonsense
30
clinvar
30
start loss
0
frameshift
25
clinvar
5
clinvar
30
inframe indel
3
clinvar
1
clinvar
4
splice donor/acceptor (+/-2bp)
9
clinvar
2
clinvar
11
splice region
7
10
1
18
non coding
96
clinvar
49
clinvar
78
clinvar
223
Total 79 23 208 132 83

Highest pathogenic variant AF is 0.00000657

Variants in LMX1B

This is a list of pathogenic ClinVar variants found in the LMX1B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-126614438-G-T Nail-patella syndrome Uncertain significance (Jan 13, 2018)913690
9-126614468-C-G Nail-patella syndrome Likely benign (Dec 23, 2023)364875
9-126614469-C-G Inborn genetic diseases Uncertain significance (Oct 30, 2023)3119454
9-126614471-G-A Inborn genetic diseases Uncertain significance (Apr 10, 2023)1475046
9-126614485-G-T Uncertain significance (Sep 13, 2022)1718454
9-126614491-C-T Likely benign (Feb 08, 2023)2811535
9-126614500-G-A Likely benign (Jul 12, 2023)2959083
9-126614506-G-A Nail-patella syndrome Conflicting classifications of pathogenicity (Jun 06, 2023)364876
9-126614507-G-A LMX1B-related disorder Uncertain significance (Sep 19, 2023)2630445
9-126614509-C-T Likely benign (Aug 13, 2022)1963646
9-126614513-G-A Uncertain significance (Nov 13, 2023)2803851
9-126614531-A-G Uncertain significance (Sep 20, 2023)2975471
9-126614543-G-A Nail-patella syndrome Uncertain significance (Jan 13, 2018)914082
9-126614548-C-T Likely benign (Sep 17, 2021)1603407
9-126614552-C-T Likely benign (Jan 22, 2024)2762805
9-126614558-C-T Uncertain significance (Nov 27, 2023)2419247
9-126614564-C-G Inborn genetic diseases Uncertain significance (Jul 20, 2021)2238801
9-126614564-C-T Nail-patella syndrome • Inborn genetic diseases Uncertain significance (Jun 22, 2023)973862
9-126614574-T-TG Pathogenic (Apr 17, 2023)2129728
9-126614579-G-A Nail-patella-like renal disease;Nail-patella syndrome Uncertain significance (Jan 25, 2024)1027208
9-126614593-G-C Nail-patella syndrome Uncertain significance (Jan 01, 2023)427734
9-126614607-C-T not specified • Nail-patella syndrome;Nail-patella-like renal disease Benign/Likely benign (Dec 09, 2023)258621
9-126614797-C-T Benign (Nov 10, 2018)1230698
9-126614883-G-A Benign (Jul 07, 2018)1225663
9-126615117-A-G Benign (Aug 20, 2018)1262332

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LMX1Bprotein_codingprotein_codingENST00000355497 886590
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.7460.254125704031257070.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.021692610.6480.00001682624
Missense in Polyphen4399.8720.430551013
Synonymous-0.8101281171.100.00000854759
Loss of Function3.56422.10.1810.00000120214

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00008820.0000882
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Essential for the specification of dorsal limb fate at both the zeugopodal and autopodal levels.;
Pathway
Primary Focal Segmental Glomerulosclerosis FSGS;Dopaminergic Neurogenesis;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways (Consensus)

Recessive Scores

pRec
0.350

Intolerance Scores

loftool
0.0982
rvis_EVS
-0.85
rvis_percentile_EVS
11.06

Haploinsufficiency Scores

pHI
0.358
hipred
Y
hipred_score
0.837
ghis
0.501

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.980

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Lmx1b
Phenotype
taste/olfaction phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype;

Zebrafish Information Network

Gene name
lmx1ba
Affected structure
glutamatergic neuron
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
in utero embryonic development;regulation of transcription, DNA-templated;multicellular organism development;dorsal/ventral pattern formation;neuron differentiation;positive regulation of transcription by RNA polymerase II;dopaminergic neuron differentiation
Cellular component
nucleus
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;metal ion binding